101 related articles for article (PubMed ID: 12111455)
1. Pergolide protects dopaminergic neurons in primary culture under stress conditions.
Gille G; Rausch WD; Hung ST; Moldzio R; Janetzky B; Hundemer HP; Kolter T; Reichmann H
J Neural Transm (Vienna); 2002 May; 109(5-6):633-43. PubMed ID: 12111455
[TBL] [Abstract][Full Text] [Related]
2. Protection of dopaminergic neurons in primary culture by lisuride.
Gille G; Rausch WD; Hung ST; Moldzio R; Ngyuen A; Janetzky B; Engfer A; Reichmann H
J Neural Transm (Vienna); 2002 Feb; 109(2):157-69. PubMed ID: 12075855
[TBL] [Abstract][Full Text] [Related]
3. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
Takashima H; Tsujihata M; Kishikawa M; Freed WJ
Exp Neurol; 1999 Sep; 159(1):98-104. PubMed ID: 10486178
[TBL] [Abstract][Full Text] [Related]
5. Comparable Neuroprotective Effects of Pergolide and Pramipexole on Ferrous Sulfate-Induced Dopaminergic Cell Death in Cell Culture.
Reichelt D; Radad K; Moldzio R; Rausch WD; Reichmann H; Gille G
CNS Neurol Disord Drug Targets; 2016; 15(10):1325-1332. PubMed ID: 27488420
[TBL] [Abstract][Full Text] [Related]
6. CDP-choline reduces dopaminergic cell loss induced by MPP(+) and glutamate in primary mesencephalic cell culture.
Radad K; Gille G; Xiaojing J; Durany N; Rausch WD
Int J Neurosci; 2007 Jul; 117(7):985-98. PubMed ID: 17613109
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture.
Gille G; Radad K; Reichmann H; Rausch WD
J Neural Transm (Vienna); 2006 Sep; 113(9):1107-18. PubMed ID: 16252065
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.
Wakamatsu M; Iwata S; Funakoshi T; Yoshimoto M
J Neurosci Res; 2008 Feb; 86(3):640-6. PubMed ID: 17896793
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of riluzole on dopamine neurons: involvement of oxidative stress and cellular energy metabolism.
Storch A; Burkhardt K; Ludolph AC; Schwarz J
J Neurochem; 2000 Dec; 75(6):2259-69. PubMed ID: 11080177
[TBL] [Abstract][Full Text] [Related]
10. Prevention of 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced nitration of tyrosine hydroxylase and neurotoxicity by EUK-134, a superoxide dismutase and catalase mimetic, in cultured dopaminergic neurons.
Pong K; Doctrow SR; Baudry M
Brain Res; 2000 Oct; 881(2):182-9. PubMed ID: 11036157
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
Shin JY; Park HJ; Ahn YH; Lee PH
J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
[TBL] [Abstract][Full Text] [Related]
12. The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity.
Mena MA; Casarejos MJ; García de Yébenes J
J Neural Transm (Vienna); 1999; 106(11-12):1105-23. PubMed ID: 10651107
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP promotes the survival of dopaminergic neurons in vitro and protects them from the toxic effects of MPP+.
Hulley P; Hartikka J; Lübbert H
J Neural Transm Suppl; 1995; 46():217-28. PubMed ID: 8821058
[TBL] [Abstract][Full Text] [Related]
14. A non-peptidyl neurotrophic small molecule for midbrain dopaminergic neurons.
Lin LF; Rubin LL; Xu M
J Neurochem; 2004 Jun; 89(6):1387-95. PubMed ID: 15189341
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress to dopaminergic neurons as models of Parkinson's disease.
Gille G; Hung ST; Reichmann H; Rausch WD
Ann N Y Acad Sci; 2004 Jun; 1018():533-40. PubMed ID: 15240412
[TBL] [Abstract][Full Text] [Related]
16. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
[TBL] [Abstract][Full Text] [Related]
17. L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function.
Espadas I; Darmopil S; Vergaño-Vera E; Ortiz O; Oliva I; Vicario-Abejón C; Martín ED; Moratalla R
Neurobiol Dis; 2012 Dec; 48(3):271-81. PubMed ID: 22820144
[TBL] [Abstract][Full Text] [Related]
18. Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium.
Koutsilieri E; Chen TS; Rausch WD; Riederer P
Eur J Pharmacol; 1996 Jun; 306(1-3):181-6. PubMed ID: 8813631
[TBL] [Abstract][Full Text] [Related]
19. 3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of L-DOPA.
Asanuma M; Miyazaki I
BMC Neurosci; 2016 Jul; 17(1):52. PubMed ID: 27456338
[TBL] [Abstract][Full Text] [Related]
20. Toxicity of 1-methyl-4-phenylpyridinium for rat dopaminergic neurons in culture: selectivity and irreversibility.
Michel PP; Dandapani BK; Knusel B; Sanchez-Ramos J; Hefti F
J Neurochem; 1990 Apr; 54(4):1102-9. PubMed ID: 1968953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
